GRIFOLS | Eiendeler



Assets Endring Dato
Alcon AG USD 30.35B 15M 2024-12
Almirall EUR 2.32B 14.19M 2024-06
Amadeus IT EUR 11.78B 260M 2024-12
Amarin USD 750.62M 49.24M 2024-09
AstraZeneca USD 104.04B 887M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Cie Automotive EUR 5.96B 129.12M 2024-12
Demant DKK 32.45B 60M 2024-12
Ence Energia y Celulosa EUR 1.7B 50.9M 2024-09
Essilor EUR 64.26B 2.77B 2024-12
Ferrovial EUR 29B 2.37B 2024-12
Fresenius EUR 43.55B 1.18B 2024-12
Fresenius Medical Care EUR 33.57B 1.06B 2024-12
Galapagos EUR 4.14B 36.48M 2024-12
Genmab DKK 45.81B 6.15B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
GRIFOLS EUR 21.41B 1.12B 2024-12
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Inditex EUR 36.09B 2.84B 2024-10
Merck EUR 50.14B 267M 2024-09
Novartis USD 102.25B 1.28B 2024-12
Philips EUR 28.98B 498M 2024-12
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 129.76B 3.29B 2024-06
Smith & Nephew USD 10.35B 188M 2024-12
UCB EUR 17.35B 1.72B 2024-12
Viscofan EUR 1.4B 5.19M 2024-12



GRIFOLS Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.